IP Verse

Coating Capsules With Active Pharmaceutical Ingredients - EP2081550

The patent EP2081550 was granted to Reliant Pharmaceuticals on May 26, 2021. The application was originally filed on Mar 9, 2007 under application number EP07752721A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP2081550

RELIANT PHARMACEUTICALS
Application Number
EP07752721A
Filing Date
Mar 9, 2007
Status
Patent Maintained As Amended
Apr 23, 2021
Grant Date
May 26, 2021
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

DEHMEL & BETTENHAUSENJan 17, 2019RUCKERLADMISSIBLE
FH SERVICESJan 17, 2019BECK GREENERADMISSIBLE

Patent Citations (52) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONDE19930030
DESCRIPTIONEP1529524
DESCRIPTIONJPH07316144
DESCRIPTIONJPS59157018
DESCRIPTIONUS2004043070
DESCRIPTIONUS2004224020
DESCRIPTIONUS2004254357
DESCRIPTIONUS2006222701
DESCRIPTIONUS4670287
DESCRIPTIONUS5478508
DESCRIPTIONUS5502077
DESCRIPTIONUS5641512
DESCRIPTIONUS5656667
DESCRIPTIONUS5681588
DESCRIPTIONUS5698594
DESCRIPTIONUS5882680
DESCRIPTIONUS6245811
DESCRIPTIONUS6350468
DESCRIPTIONUS6531150
DESCRIPTIONUS6572885
DESCRIPTIONUS6632451
DESCRIPTIONUS7153538
DESCRIPTIONWO9514460
INTERNATIONAL-SEARCH-REPORTUS2007036862
INTERNATIONAL-SEARCH-REPORTUS2007196465
INTERNATIONAL-SEARCH-REPORTUS2007212411
INTERNATIONAL-SEARCH-REPORTWO2007103557
OPPOSITIONEP1157692
OPPOSITIONUS2001006644
OPPOSITIONUS2002034546
OPPOSITIONUS2004018248
OPPOSITIONUS2005053648
OPPOSITIONUS2006034815
OPPOSITIONUS5656667
OPPOSITIONUS5861399
OPPOSITIONUS6159993
OPPOSITIONWO02100394
OPPOSITIONWO2005013940
OPPOSITIONWO2005084666
OPPOSITIONWO2006017692
OPPOSITIONWO2006017698
OPPOSITIONWO2006099618
OPPOSITIONWO2006125496
OPPOSITIONWO2007011886
OPPOSITIONWO2007016256
OPPOSITIONWO9610996
OPPOSITIONWO9906046
SEARCHWO2005013940
SEARCHWO2006017692
SEARCHWO2007011886
SEARCHWO2007016256
SEARCHWO9610996

Non-Patent Literature (NPL) Citations (17) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- BELLUZI ET AL., GASTROENTEROLOGY, (1992), vol. 102, no. 4, page A542-
DESCRIPTION- BELLUZI ET AL., N. ENGL. J. MED., (1996), vol. 334, no. 24, pages 1557 - 60-
DESCRIPTION- EBERT, "Soft Elastic Gelatin Capsules: A Unique Dosage Form", PHARMACEUTICAL TECHNOLOGY, (1978), vol. 1, no. 5-
DESCRIPTION- J. LIPID RES., (2002), vol. 43, pages 1864 - 1873-
DESCRIPTION- J. MED. CHEM., (1998), vol. 41, pages 973 - 980-
DESCRIPTION- REICH, "Chapter 11: Formulation and physical properties of soft capsules", Pharmaceutical Capsules, 2d Ed.,, PHARMACEUTICAL PRESS, (2004), pages 201 - 212-
DESCRIPTION- UNIFORMITY OF DOSAGE UNITS, pages 378 - 382-
EXAMINATION- DURRINGTON P N ET AL, "An omega-3 polyunsaturated fatty acid concentrate administered for one year decreased trigycerides in simvastatin treated patients with coronary heart disease and persisting hyperlipidemia", HEART, BMJ, LONDON, GB, (20010101), vol. 85, doi:10.1136/HEART.85.5.544, ISSN 1355-6037, pages 544 - 548, XP003011854
INTERNATIONAL-SEARCH-REPORT- "Pharmaceutical Capsules", REICH G., Formulation and physical properties of soft capsules, Chapter 11, (2004), vol. 2ND ED., pages 201 - 212, XP008101385-
INTERNATIONAL-SEARCH-REPORT- BIJU S.S. ET AL., "Dual coated erodible microcapsules for modified release of diclofenac sodium", J. PHARMACEUTICS AND BIOPHARMACEUTICS, (2004), vol. 58, pages 61 - 67, XP004519828
INTERNATIONAL-SEARCH-REPORT- YUKSEL N. ET AL., "Enhanced bioavailability of piroxicam using Gelusire 44/14 and Labrasol: in vitro and in vivo evaluation", EUROPEAN J. PHARMACEUTICS AND BIOPHARMACEUTICS, (2003), vol. 56, XP004470484
OPPOSITION- "Chapter 1", Bauer et al., Coated pharmaceutical dosage forms: Fundamentals, manufacturing techniques, biopharmaceutical aspects, test methods and raw materials, (19980000), pages 12 - 18, XP055548103-
OPPOSITION- HENNEKENS, "Fixed-Dose Combination Therapy with Statins - Strengths, Limitations, and Clinical and Regulatory Considerations", American Journal of Cardiovascular Drugs, (20080500), vol. 8, no. 3, pages 155 - 160, XP055548244-
OPPOSITION- "Omega-3-acid ethyl esters (K85EE)", Technical Information Leaflet, (20150500), pages 1 - 6, XP055548084-
OPPOSITION- REICH, "Chapter 11 - Formulation and physical properties of soft capsules", REICH, Podczeck et al., Pharmaceutical Capsules, 2nd ed., (20040000), pages 201 - 212, XP002784475-
OPPOSITION- DURRINGTON et al., "An omega-3 polyunsaturated fatty acid concentrate administered for one year decreased trigycerides in simvastatin treated patients with coronary heart disease and persisting hyperlipidemia", Heart, (20010000), vol. 85, pages 544 - 548, XP003011854
OPPOSITION- DURRINGTON P N et al., "An omega-3 polyunsaturated fatty acid concentrate administered for one year decreased trigycerides in simvastatin treated patients with coronary heart disease and persisting hyperlipidemia", Heart, (20010000), vol. 85, pages 544 - 548, XP003011854

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents